Loading Programs

← Back to Programs

Dr. Beth Y. Karlan M.D.

DirectorWomen’s Cancer Program in the Samuel Oschin Comprehensive Cancer Institute

DirectorDivision of Gynecologic Oncology

DirectorGilda Radner Hereditary Cancer Program

Board of Governors Chair in Gynecologic Oncology

ProfessorObstetrics and Gynecology

 

  • OB/GYN-Oncology

The research studies of Beth Karlan, MD, focuses on ovarian cancer specific biomarkers for early detection, prognostication and targeted/individualized therapy, and inherited cancer susceptibility.

  • Medical School: Harvard Medical School, 1982
  • Internship: Yale-New Haven Hospital, 1983
  • Residency: Yale-New Haven Hospital, 1986
  • Fellowship: UCLA Medical Center, 1989
  • Editor-in-Chief: Gynecologic Oncology, Current
  • Distinguished Service Award, Society of Gynecologic Oncology — recognizing achievements as Editor-in-Chief of Gynecologic Oncology Journal and Gynecologic Oncology Reports, 2015
  • Claudia Cohen Research Foundation Prize for Outstanding Cancer Researcher, 2015
  • Member, National Cancer Advisory Board, 2012
  • Clinical Research Professorship: American Cancer Society, 2011
  • Prize for Excellence in Ovarian Cancer Research, Gynecologic Cancer Foundation, 2008
  • Board of Governors Chair in Gynecologic Oncology, 1995

Upcoming Programs

Programs List Navigation

May 2018

Hereditary Cancer Risk Symposium 2018

Tuesday, May 1 | 7:00 pm - 9:00 pm
Temple Israel of Hollywood, 7300 Hollywood Blvd. Los Angeles, 90046 United States + Google Map

  Register Here  

Find out more »
+ Export Events